secwatch.observer — SEC 8-K summary
======================================

Issuer:     Moleculin Biotech, Inc. (MBRX)
CIK:        0001659617
Form:       8-K
Filed at:   2025-11-28T23:59:59+00:00
Accession:  0001437749-25-036488
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 3.03, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Moleculin Biotech announces 1-for-25 reverse stock split effective Dec 1, 2025
------------------------------------------------------------------------------

- Reverse stock split at 1:25 ratio effective 12:01 a.m. ET on December 1, 2025.
- Outstanding shares reduced from ~51.6M to ~2.07M; authorized shares remain at 500M.
- Series E and F warrants have potential exercise price adjustments based on VWAP.
- No fractional shares issued; cash paid in lieu of fractional interests.
- Ticker MBRX unchanged; new CUSIP number 60855D408.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1659617/000143774925036488/0001437749-25-036488-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1659617/000143774925036488/mbrx20251124_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-036488

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer